|
|
|
Orphazyme A Accounts Receivables Turnover Ratio from the fourth quarter 2021 to the fourth quarter 2020
Quarterly Results, Trends, Rankings, Statistics
Orphazyme A's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2021 to a ratio of 5.17, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2021. Orphazyme A's Accounts Receivable average collection period in the Dec 31 2021 quarter, | |